 |
|
|
| |
Efficacy and Safety of B/F/TAF in Children and Infants Aged ≥1 Month, Weighing 3 to <25 kg: Week 24
|
| |
| |
CROI 2026 Feb 22-25 Denver
Eva Natukunda1, Peter Elyanu2, Jeanne Coetzee3, Samantha Fry4, Elizabeth Helstr.m5, Umesh Lalloo6, Afaaf Liberty7, Kathleen A. McGann8, Carina A. Rodriguez9, Natella Rakhmanina10, Athira Sudhakaran11, Vinicius Vieira11, Kathryn Kersey11, Flavia Matovu Kiweewa12
1Joint Clinical Research Centre, Kampala, Uganda, 2Baylor College of Medicine Children's Foundation, Kampala, Uganda, 3Wits Reproductive Health and HIV Institute, Johannesburg, South Africa, 4Stellenbosch University, Cape Town, South Africa, 5Be Part Yoluntu Centre NPC, Paarl, South Africa, 6Durban University of Technology, Durban, South Africa, 7Chris Hani Baragwanath Hospital, Soweto, South Africa, 8Duke University Medical Center, Durham, NC, USA, 9University of South Florida, Tampa, FL, USA, 10Children's National Hospital, Washington, DC, USA, 11Gilead Sciences, Inc, Foster City, CA, USA, 12Malawi College of Medicine–Johns Hopkins University Research Project, Kampala, Uganda
|
| |
|
|
|
|
|
